Company Filing History:
Years Active: 2018
Title: Bruce Szczpankiewicz: Innovator in Nicotinamide Mononucleotide Derivatives
Introduction
Bruce Szczpankiewicz is a notable inventor based in Hopkinton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of nicotinamide mononucleotide derivatives. With a total of two patents to his name, Szczpankiewicz is recognized for his innovative approaches to enhancing cellular health.
Latest Patents
Szczpankiewicz's latest patents focus on nicotinamide mononucleotide derivatives and their various applications. The inventions relate to compositions of these derivatives and methods for their preparation. They also encompass pharmaceutical compositions and nutritional supplements that contain nicotinamide mononucleotide derivatives. Importantly, these inventions promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues. This advancement is crucial for treating diseases and improving cell and tissue survival.
Career Highlights
Bruce Szczpankiewicz is currently associated with Metro International Biotech, LLC, where he continues to push the boundaries of biotechnological research. His work has the potential to impact various therapeutic areas, particularly those related to cellular health and longevity.
Collaborations
Szczpankiewicz has collaborated with esteemed colleagues such as Karl D. Normington and David Andrew Sinclair. These partnerships have likely contributed to the depth and breadth of his research endeavors.
Conclusion
In summary, Bruce Szczpankiewicz is a prominent inventor whose work on nicotinamide mononucleotide derivatives is paving the way for innovative treatments in biochemistry. His contributions are significant in the quest for enhancing cellular health and longevity.